Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tectonic Therapeutic (TECX) Non-Current Debt (2021 - 2023)

Tectonic Therapeutic (TECX) has 3 years of Non-Current Debt data on record, last reported at $15.4 million in Q1 2023.

  • On a quarterly basis, Non-Current Debt rose 2.24% to $15.4 million in Q1 2023 year-over-year; TTM through Mar 2023 was $15.4 million, a 2.24% increase, with the full-year FY2022 number at $15.3 million, up 2.21% from a year prior.
  • Non-Current Debt reached $15.4 million in Q1 2023 per TECX's latest filing, up from $15.3 million in the prior quarter.
  • Over the last five years, Non-Current Debt for TECX hit a ceiling of $15.4 million in Q1 2023 and a floor of $14.9 million in Q4 2021.
  • A 3-year average of $15.2 million and a median of $15.2 million in 2022 define the central range for Non-Current Debt.
  • Peak YoY movement for Non-Current Debt: rose 2.21% in 2022, then increased 2.24% in 2023.
  • Tracing TECX's Non-Current Debt over 3 years: stood at $14.9 million in 2021, then increased by 2.21% to $15.3 million in 2022, then increased by 0.52% to $15.4 million in 2023.
  • Business Quant data shows Non-Current Debt for TECX at $15.4 million in Q1 2023, $15.3 million in Q4 2022, and $15.2 million in Q3 2022.